apoptosis – mechanisms and role in cancer therapy
DESCRIPTION
Apoptosis – mechanisms and role in cancer therapy. TYPES OF CELL DEATH: Necrotic or apoptotic. APOPTOSIS. External signals. WHEN DOES APOPTOSIS OCCUR?. Normal development e.g. immune system. WHEN DOES APOPTOSIS OCCUR?. Disease states e.g. Alzheimer’s disease. Amyloid plaques in the brain. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/1.jpg)
Apoptosis – mechanisms and role in
cancer therapy
![Page 2: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/2.jpg)
TYPES OF CELL DEATH: Necrotic or apoptotic
![Page 3: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/3.jpg)
APOPTOSIS
![Page 5: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/5.jpg)
Normal development e.g. immune system
WHEN DOES APOPTOSIS OCCUR?
![Page 6: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/6.jpg)
Disease states e.g. Alzheimer’s disease
WHEN DOES APOPTOSIS OCCUR?
Amyloid plaques in the brain
![Page 7: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/7.jpg)
Caspases – key executioners of apoptosis
(cysteinyl aspartate specific proteases)
Highly conserved proteasesinactive zymogensCaspases divided into Group I
Inflammatory caspasesCaspases
1,4,5,11,12,13,14Group II
Initiator caspases Caspases 2,8,9,10
Group IIIEffector caspases:
caspases 3,6,7
![Page 8: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/8.jpg)
Caspase structure
![Page 9: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/9.jpg)
Properties of proteases
Irreversible -Autocatalytic: triggered by cofactor
binding or inhibitor removalProteases can regulate their own
activationprotease inhibitorsspecificity
![Page 10: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/10.jpg)
Caspase structure3 domains 1) highly variable NH2 domain2) large subunit (p20; ~20kD)3) small subunit ( p10; ~10kD)
Highly specific absolute requirement for cleavage after aspartic acid
recognition of at least 4 amino acids NH2 terminals to the cleavage site
![Page 11: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/11.jpg)
Caspase structure
2 key features: variable N domain regulates activation all domains derived from proenzyme precursor by cleavage specific sitesScheme of procaspase activation:Cleavage of the procaspase at the specific Asp-X bonds leads to the formation of the mature caspase, which comprises the heterotetramer p202–p102, and the release of the prodomain.
![Page 12: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/12.jpg)
Structure of caspase-3 heterotetramerEach heterodimer is formed by hydrophobic interactions resulting in the formation of mostly parallel ß-sheets, composed of 6 antiparallel ß-strands.
Two heterodimers fit together with formation of a 12-stranded ß-sheet that is sandwiched by helices. N and C termini of the small and large protease subunits are indicated
![Page 13: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/13.jpg)
Basic apoptotic machinery
DNA fragmentation,chromatin condensation,membrane blebbing, cell shrinkage & disassembly into apoptotic bodies engulfment
Initiator caspases inactivate proteins that protect cells from apoptosis Effector caspases are responsible for cellular changes associated with apoptosis.
![Page 14: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/14.jpg)
How do caspases disassemble a cell? It slices, it dices!
Selective cleavage of specific proteins
eg bcl-2, or CAD/ICAD
e.g. nuclear lamins
eg. Gelsolin
![Page 15: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/15.jpg)
What triggers apoptosis?• Growth factor withdrawal• Specific ‘death ligands • Loss of contact with surroundings• Irreparable internal damage• Conflicting signals for cell
division
![Page 16: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/16.jpg)
How are caspases activated? Proteolytic cleavage
Cleavage of the procaspase at the specific Asp-X bonds leads to the formation of the mature caspase, which comprises the heterotetramer p202–p102, and the release of the prodomain.
2 key features: variable N domain regulates
activation all domains derived from
precursor by cleavage specific sites
![Page 17: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/17.jpg)
How are caspases activated?
Induced proximity
aggregation of multiple procaspase-8 molecules into close proximity somehow results in cross-activation
![Page 18: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/18.jpg)
How are caspases activated?
Holoenzyme formation
Activation of caspase-9 is mediated by means of conformational change, not proteolysis
![Page 19: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/19.jpg)
nematode - C.elegansOne of the apoptotic pathways is triggered by internal signals- CEDCED-3 & 4 promote apoptosis CED-9 inhibits apoptosisApoptotic stimuli causes CED-9 dissociation by EGL-1 thereby activating CED-3.
![Page 20: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/20.jpg)
Caspase signaling in Mammalian systems
IN Lavrik et al The Journal of Clinical Investigation 115(10):2665-72. (October 2005)
![Page 21: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/21.jpg)
Mammalian systems Mammals
![Page 22: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/22.jpg)
External signalsdriven by death receptors (DR) e.g. CD95 (or Fas/Apo)
Each CD95L trimer binds to 3 CD95 leading to DD clustering.
FADD ( Fas associated death domain/ Mort 1) binds via its own DD
Caspase –8 oligomerisation drives activation through self cleavage
Caspase –8 then activates downstream effector caspases like caspase –9 (CED-9 homolog)
Apoptosis initiation
![Page 23: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/23.jpg)
Internal signals
![Page 24: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/24.jpg)
BCL-2
![Page 25: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/25.jpg)
DNA damageDeath receptorsGrowth factor
withdrawal
TRIGGERP53Bcl-2 familyCytochrome concogenes
REGULATOR
Apaf-1Caspases
EXECUTIONER
![Page 26: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/26.jpg)
Green and Kroemer The Journal of Clinical Investigation 115(10):2610-17 (October 2005)
![Page 27: Apoptosis – mechanisms and role in cancer therapy](https://reader036.vdocuments.mx/reader036/viewer/2022070503/56815693550346895dc43a91/html5/thumbnails/27.jpg)
Chapter 12: Cellular & Mol Biology by Knowles and Selby
AND/OR Science (1998) Vol 281: No 5381; pgs 1298-1326
AND/OR J. Clin Invest (10 Oct 2005) 115(10):2665-72
AND/ORCancer Biology by RJB King pgs 160-167
AND/OR
References
NATURE | VOL 407 | 12 OCTOBER 2000 pp770-776The biochemistry of apoptosis by M.O. Hengartner
OptionalNATURE REVIEWS MOLECULAR CELL BIOLOGY Vol 5 | NOV 2004 | 897Molecular mechanisms of caspase regulation during apoptosisStefan J. Riedl and Yigong Shi(Only read it if you want to know more about caspase structure)